Skip to content

Transverse Abdominis Plane Block for Anterior Approach Spine Surgery

Transverse Abdominis Plane Block for Anterior Approach Spine Surgery: A Prospective Randomized Study

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02884440
Acronym
TAP ALIF
Enrollment
43
Registered
2016-08-31
Start date
2016-11-07
Completion date
2019-05-25
Last updated
2023-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain, Spine Surgery, Spondylolisthesis

Brief summary

Therapeutic, prospective, randomized, double blind, placebo-controlled, in intention to treat, monocentric study to evaluate the analgesic efficacy of a bilateral TAP block after spine surgery with 24 hours morphine consumption

Detailed description

ALIF is a commonly performed procedure for the treatment of degenerative diseases of the lumbar spine or spondylolisthesis. This technique has many advantages attributed to the absence of posterior spinal muscular pain, a more direct visualization of the disk space, lower incidence of neurological injuries… However, patients experienced moderate to high post operative parietal abdominal pain due to this specific anterior approach. The systematic need for opioids administration may cause many complications and delay the post operative recovery time. The TAP block has been described as an effective pain control technique after various lower abdominal surgeries, reducing both pain scores and 24 hours opioids consumption. However the analgesic efficacy of this technique on specific parietal abdominal pain experienced after spine surgery by anterior approach is not clear

Interventions

DRUGTAP block ropivacaine
DRUGGeneral anesthesia

Induction PROPOFOL 10mg/ml REMIFENTANIL 50 μg/ml CISATRACURIUM 2mg/ml if necessary DEXAMETHASONE 8 mg KETAMINE 0,15mg/kg Maintenance PROPOFOL 10mg/ml REMIFENTANIL 50 μg/ml

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with age above 18 years old * Patients scheduled for spine surgery by anterior approach * Patient who signed an informed consent form

Exclusion criteria

* Allergy to ropivacaine * Weight \< 50 kg * Contra indication to TAP block : sepsis in the point of draining, bleeding disorder * Contra indication to paracetamol: severe hepatic insufficiency * Contra indication to ketoprofen: age ≥ 75 years, renal insufficiency, previous gastric ulcer, allergy * Contra indication to nefopam: severe cardiac insufficiency, glaucoma, prostate hypertrophy, allergy * Known allergy to active substance or at least to one excipient (propofol, paracetamol, morphine, remifentanil, cisatracurium) * Allergy to fentanyl, atracurium, or benzin sulfonic acid derivative, to propacetamol * Convulsions or previous convulsive disorder * Severe respiratory insufficiency * Abnormal hemostasis or anticoagulant treatment because of possible intramuscular injection * Morphine intake 24 hours before surgery * Chronic use of morphine, gabapentin, pregabalin * Pregnancy or breastfeeding * Patient unable to use Patient Controlled Analgesia (PCA) (old patient depends…) * Patients subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

Design outcomes

Primary

MeasureTime frame
Morphine consumption in the first 24 hours after spine surgery by anterior approach24 hours

Secondary

MeasureTime frameDescription
Morphine consumption in the first 48 hours after spine surgery by anterior approach48 hours
Assessment of pain1, 6, 12, 24 and 48 hoursNumerical Analogue score
Assessment of post operative nausea or vomiting48 hoursOccurence of nausea or vomiting episodes over 48 hours
Delay before resumption of transitDay 1Number of days between end of surgery and resumption of transit
Delay before the first liftDay 1Number of hours between end of surgery and the first lift
Duration of hospitalizationDay 1
Patient satisfaction48 hoursSatisfaction questionnaire
Delay before first morphine administrationDay 1Number of hours between end of surgery and first morphine administration

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026